Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Jen Tang

Showing results (101-110 of 236) with videos related to

Pageof 24
Sort By:
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 21, 2007
Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infectionShyh Ren Chiang, Hung Jen Tang, Ping Chin Chang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 14, 2017
Salvage therapy with intravenous fosfomycin plus ceftriaxone for necrotizing fasciitis caused by penicillin-nonsusceptible Streptococcus pneumoniaeChun-Cheng Zhang, Tzu-Chieh Weng, Bo-An Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
Antimicrobial-resistant nocardia isolates, Taiwan, 1998-2009Chih-Cheng Lai, Wei-Lun Liu, Wen-Chien Ko, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 13, 2005
In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139Bo-An Su, Hung-Jen Tang, Yin-Yi Wang, et al.
Scientific Reports|July 28, 2017
Klebsiella pneumoniae Isolates from Meningitis: Epidemiology, Virulence and Antibiotic ResistanceYee-Huang Ku, Yin-Ching Chuang, Chi-Chung Chen, et al.
Clinical Therapeutics|August 19, 2019
Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae BacteremiaChing-Chi Lee, Chao-Yung Yang, Chung-Hsun Lee, et al.
Expert Review of Anti-Infective Therapy|March 7, 2023
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trialsJheng-Yan Wu, Po-Yu Huang, Ting-Hui Liu, et al.
Emerging Infectious Diseases|October 22, 2004
Vibrio vulnificus in TaiwanPo-Ren Hsueh, Ching-Yih Lin, Hung-Jen Tang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 18, 2017
The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organismsPing-Chin Chang, Chi-Chung Chen, Ying Chen Lu, et al.
International Journal of Antimicrobial Agents|July 12, 2017
Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremiaChing-Chi Lee, Jiun-Ling Wang, Chung-Hsun Lee, et al.
Pageof 24

Showing results (101-110 of 236) with videos related to

Sort By:
Pageof 24
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|April 21, 2007
Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infectionShyh Ren Chiang, Hung Jen Tang, Ping Chin Chang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|January 14, 2017
Salvage therapy with intravenous fosfomycin plus ceftriaxone for necrotizing fasciitis caused by penicillin-nonsusceptible Streptococcus pneumoniaeChun-Cheng Zhang, Tzu-Chieh Weng, Bo-An Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 4, 2011
Antimicrobial-resistant nocardia isolates, Taiwan, 1998-2009Chih-Cheng Lai, Wei-Lun Liu, Wen-Chien Ko, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 13, 2005
In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139Bo-An Su, Hung-Jen Tang, Yin-Yi Wang, et al.
Scientific Reports|July 28, 2017
Klebsiella pneumoniae Isolates from Meningitis: Epidemiology, Virulence and Antibiotic ResistanceYee-Huang Ku, Yin-Ching Chuang, Chi-Chung Chen, et al.
Clinical Therapeutics|August 19, 2019
Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae BacteremiaChing-Chi Lee, Chao-Yung Yang, Chung-Hsun Lee, et al.
Expert Review of Anti-Infective Therapy|March 7, 2023
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trialsJheng-Yan Wu, Po-Yu Huang, Ting-Hui Liu, et al.
Emerging Infectious Diseases|October 22, 2004
Vibrio vulnificus in TaiwanPo-Ren Hsueh, Ching-Yih Lin, Hung-Jen Tang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 18, 2017
The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organismsPing-Chin Chang, Chi-Chung Chen, Ying Chen Lu, et al.
International Journal of Antimicrobial Agents|July 12, 2017
Clinical benefits of antimicrobial de-escalation in adults with community-onset monomicrobial Escherichia coli, Klebsiella species and Proteus mirabilis bacteremiaChing-Chi Lee, Jiun-Ling Wang, Chung-Hsun Lee, et al.
Pageof 24